AB-225

N/A

Report date: 2024/03/26 16:18:36

Base Information

Drug NameAB-225
Drug Alias NameAB-225
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord InjuriesIntervertebral Disc Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAngiocrine Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesAngiocrine Bioscience Inc
Inactive CompaniesN/A
Active IndicationsSpinal Cord InjuriesIntervertebral Disc Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A